Cargando…
A review on COVID-19 transmission, epidemiological features, prevention and vaccination
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047653/ https://www.ncbi.nlm.nih.gov/pubmed/35658107 http://dx.doi.org/10.1515/mr-2021-0023 |
_version_ | 1784695769199017984 |
---|---|
author | Zhang, Yuqin Wu, Gonghua Chen, Shirui Ju, Xu Yimaer, Wumitijiang Zhang, Wangjian Lin, Shao Hao, Yuantao Gu, Jing Li, Jinghua |
author_facet | Zhang, Yuqin Wu, Gonghua Chen, Shirui Ju, Xu Yimaer, Wumitijiang Zhang, Wangjian Lin, Shao Hao, Yuantao Gu, Jing Li, Jinghua |
author_sort | Zhang, Yuqin |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R(0) of COVID-19 was 2.9 (95% CI: 2.7–3.1), and the estimates in Africa and Europe could be higher. The median R(t) could decrease by 23–96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R(0) in our meta-analysis, there should be at least 93.3% (95% CI: 89.9–96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness. |
format | Online Article Text |
id | pubmed-9047653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-90476532022-06-04 A review on COVID-19 transmission, epidemiological features, prevention and vaccination Zhang, Yuqin Wu, Gonghua Chen, Shirui Ju, Xu Yimaer, Wumitijiang Zhang, Wangjian Lin, Shao Hao, Yuantao Gu, Jing Li, Jinghua Med Rev (Berl) Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections and millions of deaths over past two years. Currently, many countries have still not been able to take the pandemic under control. In this review, we systematically summarized what we have done to mitigate the COVID-19 pandemic, from the perspectives of virus transmission, public health control measures, to the development and vaccination of COVID-19 vaccines. As a virus most likely coming from bats, the SARS-CoV-2 may transmit among people via airborne, faecal-oral, vertical or foodborne routes. Our meta-analysis suggested that the R(0) of COVID-19 was 2.9 (95% CI: 2.7–3.1), and the estimates in Africa and Europe could be higher. The median R(t) could decrease by 23–96% following the nonpharmacological interventions, including lockdown, isolation, social distance, and face mask, etc. Comprehensive intervention and lockdown were the most effective measures to control the pandemic. According to the pooled R(0) in our meta-analysis, there should be at least 93.3% (95% CI: 89.9–96.2%) people being vaccinated around the world. Limited amount of vaccines and the inequity issues in vaccine allocation call for more international cooperation to achieve the anti-epidemic goals and vaccination fairness. De Gruyter 2022-03-02 /pmc/articles/PMC9047653/ /pubmed/35658107 http://dx.doi.org/10.1515/mr-2021-0023 Text en © 2021 Yuqin Zhang et al., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Review Zhang, Yuqin Wu, Gonghua Chen, Shirui Ju, Xu Yimaer, Wumitijiang Zhang, Wangjian Lin, Shao Hao, Yuantao Gu, Jing Li, Jinghua A review on COVID-19 transmission, epidemiological features, prevention and vaccination |
title | A review on COVID-19 transmission, epidemiological features, prevention and vaccination |
title_full | A review on COVID-19 transmission, epidemiological features, prevention and vaccination |
title_fullStr | A review on COVID-19 transmission, epidemiological features, prevention and vaccination |
title_full_unstemmed | A review on COVID-19 transmission, epidemiological features, prevention and vaccination |
title_short | A review on COVID-19 transmission, epidemiological features, prevention and vaccination |
title_sort | review on covid-19 transmission, epidemiological features, prevention and vaccination |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047653/ https://www.ncbi.nlm.nih.gov/pubmed/35658107 http://dx.doi.org/10.1515/mr-2021-0023 |
work_keys_str_mv | AT zhangyuqin areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT wugonghua areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT chenshirui areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT juxu areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT yimaerwumitijiang areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT zhangwangjian areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT linshao areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT haoyuantao areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT gujing areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT lijinghua areviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT zhangyuqin reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT wugonghua reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT chenshirui reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT juxu reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT yimaerwumitijiang reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT zhangwangjian reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT linshao reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT haoyuantao reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT gujing reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination AT lijinghua reviewoncovid19transmissionepidemiologicalfeaturespreventionandvaccination |